Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai InnoStar Bio-tech Co Days Payable?
Shanghai InnoStar Bio-tech CoSHSE:688710 +8.28%33 Days Payable is 35.71 as of Mar. 2026, which is 29% below its 10-year median of 50.58. GuruFocus rates SHSE:688710 with a GF Score™ of 33/100. The stock has 8 warning signs investors should review. Among 925 Drug Manufacturers companies, Shanghai InnoStar Bio-tech Co ranks worse than 83.68% on this metric.
The historical rank and industry rank for Shanghai InnoStar Bio-tech Co's Days Payable or its related term are showing as below:
SHSE:688710'
s Days Payable Range Over the Past 10 Years
Min: 31.5 Med: 50.58 Max: 63.69
Current: 39.19
During the past 7 years, Shanghai InnoStar Bio-tech Co's highest Days Payable was 63.69. The lowest was 31.50. And the median was 50.58.
SHSE:688710's Days Payable is ranked worse than 83.68% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:688710: 39.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688710 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Shanghai InnoStar Bio-tech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai InnoStar Bio-tech Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai InnoStar Bio-tech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai InnoStar Bio-tech Co's Days Payable falls into.
Shanghai InnoStar Bio-tech Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a Days Payable of 35.71 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai InnoStar Bio-tech Co and its competitors. This is 29% below median its historical median of 50.58. Over the past decade, Shanghai InnoStar Bio-tech Co's Days Payable has ranged from 31.50 to 63.69. According to the industry distribution chart, Shanghai InnoStar Bio-tech Co ranks #774 out of 925 companies in the Drug Manufacturers industry, placing it in the top 83.7%.
Is Shanghai InnoStar Bio-tech Co's Days Payable too high?
Shanghai InnoStar Bio-tech Co's current Days Payable of 35.71 is 29% below median its 10-year median of 50.58. Over the past 10 years, this metric has ranged from a low of 31.50 to a high of 63.69. The Drug Manufacturers industry median Days Payable is 90.38. Shanghai InnoStar Bio-tech Co's value of 35.71 is 60.5% below this industry median. Based on the distribution chart, Shanghai InnoStar Bio-tech Co ranks #774 out of 925 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai InnoStar Bio-tech Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai InnoStar Bio-tech Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shanghai InnoStar Bio-tech Co ranks #774 out of 925 companies for Days Payable. This places Shanghai InnoStar Bio-tech Co in the lower half of its industry. The industry median Days Payable is 90.38. Shanghai InnoStar Bio-tech Co's value of 35.71 is 60.5% below this benchmark. Historically, Shanghai InnoStar Bio-tech Co's own Days Payable has ranged from 31.50 to 63.69 over the past decade. While the company's 10-year median is 50.58 vs. the industry median of 90.38, Shanghai InnoStar Bio-tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai InnoStar Bio-tech Co's current Days Payable of 35.71 is 60.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai InnoStar Bio-tech Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai InnoStar Bio-tech Co's current Days Payable is 35.71, which is 29% below median its own 10-year median of 50.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai InnoStar Bio-tech Co stock overvalued right now?
Shanghai InnoStar Bio-tech Co (SHSE:688710) has a current Days Payable of 35.71. The current Days Payable is 35.71, which is 29% below median its 10-year median of 50.58 and 60.5% below the Drug Manufacturers industry median of 90.38. Shanghai InnoStar Bio-tech Co's overall GF Score™ is 33/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai InnoStar Bio-tech Co (SHSE:688710), the current Days Payable is 35.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shanghai InnoStar Bio-tech Co Business Description
Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.
33GF Score
Get the complete analysis for SHSE:688710
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688710 has been successfully added to your 
